Warenkorb -  AGBs -  Datenschutz -  Contact us   

 

Explode tree
Collapse tree

Test.


Cannabinoids and Pain


NAROUZE --- Neuerscheinung!!

Cannabinoids and Pain

339 Seiten, 1. Auflage, 2021
60 Abbildungen

  • Provides a balanced view on cannabis and cannabinoids for pain by experts in the field
  • Presents the physiology of the endocannabinoid system
  • Offers strategies on when to recommend medical cannabis and when not
  • Discusses pros/cons of cannabis as a substitute for opioids
This book presents a well-balanced view of the potential medical use of cannabinoids in pain. It comprehensively covers the current challenges with medical cannabis utilization and provides recommendations for research and future directions.

Organized into nine sections, the book beings with an introduction to medical cannabis, including its history, regulations, and the general attitudes of pain physicians on cannabis. Section two explores the biological effects of marijuana via the endocannabinoid system and its complex structure of receptors and enzymes. Sections three, four, and five then delve further into pharmacology and the mechanisms of action applicable to cannabinoids in managing pain.

Timely and socially conscious, section six examines the benefits of substituting opioids with cannabinoids for preoperative management. Echoing the book's well-rounded content, sections seven and eight consider the challenges with medical cannabis, including safety and quality control, brain development risks, vaping hazards, and withdrawal. The book then closes with a look at the future of cannabis in medical research.

Thoroughly and equitably composed, Cannabinoids and Pain is an invaluable resource for primary care physicians, pain and palliative care physicians, and oncologists.

Contents Overview
  • Introduction to Cannabis
  • Cannabinoids Pharmacology
  • Pharmaceutical Cannabinoids
  • Medical Cannabis
  • Cannabinoids and Pain
  • Cannabinoids as a Substitute for Opioids
  • The Challenges with Medical Cannabis
  • Cannabis Impairment and Use Disorder
  • Cannabinoids Future Directions

€ 139,09
   
versandkostenfrei - in acht bis zehn Werktagen lieferbar Anzahl:
Preis: € 139,09